Khaled Sanbar – VJRegenMed https://mirror.vjregenmed.com The Video Journal of Regenerative Medicine Wed, 25 Aug 2021 11:23:39 +0000 en-US hourly 1 https://wordpress.org/?v=6.5.2 https://d2xz56kaqxj8if.cloudfront.net/wp-content/uploads/2023/09/12102509/VJR-Favicon.png Khaled Sanbar – VJRegenMed https://mirror.vjregenmed.com 32 32 Unmet needs in the treatment of glioblastoma https://mirror.vjregenmed.com/video/mknnduxmb1w-unmet-needs-in-the-treatment-of-glioblastoma/ Wed, 19 Aug 2020 16:20:19 +0000 http://vjregenmed.devbrandcast.com/video/mknnduxmb1w-unmet-needs-in-the-treatment-of-glioblastoma/ Khaled Sanbar, MD, PhD, of Johns Hopkins Hospital, Baltimore, MD, highlights the challenges faced in the treatment of glioblastoma and the potential of CAR T-cell therapy in treating this highly malignant brain tumor. This interview was recorded via an online conference call with The Video Journal of Regenerative Medicine (VJRegenMed).

]]>
Barriers to CAR-T for glioblastoma https://mirror.vjregenmed.com/video/gx_lvzkvm2y-barriers-to-car-t-for-glioblastoma/ Wed, 19 Aug 2020 16:20:19 +0000 http://vjregenmed.devbrandcast.com/video/gx_lvzkvm2y-barriers-to-car-t-for-glioblastoma/ Khaled Sanbar, MD, PhD, Johns Hopkins Hospital, Baltimore, MD, explores challenges in implementing CAR T-cell therapies for glioblastoma routine treatment, including administration, antigen heterogeneity of tumors, and persistence of the CAR T-cells. This interview was recorded via an online conference call with The Video Journal of Regenerative Medicine (VJRegenMed).

]]>